SLCO1B1 c.-61-2392G>A

Variant ID: 12-21292056-G-A

NM_006446.4(SLCO1B1):c.-61-2392G>A

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes.

The Pharmacogenomics Journal
Choi, Jihoon J; Tantisira, Kelan G KG; Duan, Qing Ling QL
Publication Date: 2019-04

Variant appearance in text: rs3829310
PubMed Link: 30214008
Variant Present in the following documents:
  • NIHMS1503453-supplement-3.xlsx, sheet 1
View BVdb publication page



Flavopiridol pharmacogenetics: clinical and functional evidence for the role of SLCO1B1/OATP1B1 in flavopiridol disposition.

Plos One
Ni, Wenjun W; Ji, Jia J; Dai, Zunyan Z; Papp, Audrey A; Johnson, Amy J AJ; Ahn, Sunjoo S; Farley, Katherine L KL; Lin, Thomas S TS; Dalton, James T JT; Li, Xiaobai X; Jarjoura, David D; Byrd, John C JC; Sadee, Wolfgang W; Grever, Michael R MR; Phelps, Mitch A MA
Publication Date: 2010-11-01

Variant appearance in text: rs3829310
PubMed Link: 21072184
Variant Present in the following documents:
  • Main text
View BVdb publication page



Genotyping panel for assessing response to cancer chemotherapy.

Bmc Medical Genomics
Dai, Zunyan Z; Papp, Audrey C AC; Wang, Danxin D; Hampel, Heather H; Sadee, Wolfgang W
Publication Date: 2008-06-11

Variant appearance in text: rs3829310
PubMed Link: 18547414
Variant Present in the following documents:
  • 1755-8794-1-24-S1.xls, sheet 1
View BVdb publication page